CASC4/GOLM2 drives high grade serous carcinoma anoikis resistance through the recycling of EGFR

Cancer Gene Therapy, Published online: 29 November 2023; doi:10.1038/s41417-023-00703-1CASC4/GOLM2 drives high grade serous carcinoma anoikis resistance through the recycling of EGFR

https://www.nature.com/articles/s41417-023-00703-1

Source: Cancer Gene Therapy - November 29, 2023 Category: Cancer & Oncology Authors: Jaidev Bapat Tomomi M. Yamamoto Elizabeth R. Woodruff Lubna Qamar Railey G. Mikeska Katherine M. Aird Zachary L. Watson Lindsay W. Brubaker Benjamin G. Bitler Source Type: research